TY - JOUR
T1 - Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2 and vascular endothelial growth factor levels in acute coronary syndromes
AU - Lee, KW
AU - Lip, Gregory
AU - Blann, Andrew
PY - 2004/10/19
Y1 - 2004/10/19
N2 - BACKGROUND: Angiopoietin (Ang) -1 and -2, their receptor Tie-2, and vascular endothelial growth factor (VEGF) regulate angiogenesis and may be important in myocardial collateral development. Elevated levels of growth factors and their receptors are reported in myocardial infarction (MI), but changes after an acute coronary event are unknown. METHODS AND RESULTS: Plasma Ang-1, Ang-2, Tie-2, and VEGF levels were measured on admission (baseline) and at 48 hours (acute stage) in 126 patients with acute coronary syndrome (82 MI, 44 unstable angina pectoris). Baseline levels were compared with those of 40 patients with stable angina and 40 healthy controls. Measurements were repeated in 38 MI patients at 6 and 18 weeks (chronic stage). Baseline Ang-2 and Tie-2 levels were highest in MI patients (P
AB - BACKGROUND: Angiopoietin (Ang) -1 and -2, their receptor Tie-2, and vascular endothelial growth factor (VEGF) regulate angiogenesis and may be important in myocardial collateral development. Elevated levels of growth factors and their receptors are reported in myocardial infarction (MI), but changes after an acute coronary event are unknown. METHODS AND RESULTS: Plasma Ang-1, Ang-2, Tie-2, and VEGF levels were measured on admission (baseline) and at 48 hours (acute stage) in 126 patients with acute coronary syndrome (82 MI, 44 unstable angina pectoris). Baseline levels were compared with those of 40 patients with stable angina and 40 healthy controls. Measurements were repeated in 38 MI patients at 6 and 18 weeks (chronic stage). Baseline Ang-2 and Tie-2 levels were highest in MI patients (P
UR - http://www.scopus.com/inward/record.url?scp=6444222152&partnerID=8YFLogxK
U2 - 10.1161/01.CIR.0000138112.90641.7F
DO - 10.1161/01.CIR.0000138112.90641.7F
M3 - Article
C2 - 15302795
SN - 1524-4539
VL - 110
SP - 2355
EP - 2360
JO - Circulation
JF - Circulation
IS - 16
ER -